VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty by Leading Law Firm Bleichmar Fonti & Auld LLP; Contact the Firm for More Details NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- If you are a shareholder of Ventyx Biosciences, you are encouraged to obtain additional information by contacting Ross Shikowitz at ross@bfalaw.com,...

VTYX Stockholders are Encouraged to Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Ventyx Biosciences, Inc. Class Action Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug

Ventyx Biosciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 30, 2024 deadline Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ventyx Biosciences, Inc....

VTYX STOCKHOLDER NEWS: Contact Robbins LLP for Information Regarding the Ventyx Biosciences, Inc. Class Action Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug

Ventyx Biosciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 30, 2024 deadline Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, March 11, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ventyx Biosciences, Inc....